Prolactinoma
NEJM 349:2035-2041, Schlechte,J.A., 2003
Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia
NEJM 349:2023-2033, Colao,A.,et al, 2003
Management of Pituitary Tumors
Ann Int Med 129:472-483, Shimon,I.&Melmed,S., 1998
Diagnosis and Management of Pituitary Tumours
BMJ 308:1087-1091, Levy,A.&Lightman,S.L., 1994
Relapse of Hyperprolactinemia Revisited
NEJM 329:1357, Serri,O.,et al, 1993
Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991
Hyperprolactinaemia, Common and Treatable
BMJ 297:701-702, Hartog,M.&Hull,M.G.R., 1988
Hyperprolactinaemia:When Is a Prolactinoma Not a Prolactinoma? Editorial
Lancet 2:1002-1004, , 1987
Primary Radiotherapy of Prolactinomas, Eight-to 15-Year Follow-Up
Am J Med 83:49-58, Mehta,A.E.,et al, 1987
Development of Pituitary Adenoma in Women with Hyper-prolactinaemia
BMJ 288:515-518, Pontiroli,A.E.,et al, 1984
Long-Term Follow-Up of Transphenoidal Selective Adenomectomy for Prolactinoma
JAMA 252:921-924, Rodman,E.F.,et al, 1984
Pergolide for the Treatment of Pituitary Tumors Secreting Prolactin or Growth Hormone
NEJM 309:704-709, Kleinberg,D.K.,et al, 1983
Microadenomas Of The Pituitary & Abnormal Sellar Tomograms In An Unselected Autopsy Series
NEJM 304:156-158, Burrow,G.N.,et al, 1981
Prolactinoma:A Question of Rational Treatment
BMJ 283:1561-1562, Edwards,C.R.W.,et al, 1981
Management of Hormone-Secreting Pituitary Adenomas
NEJM 302:210-214, Zervas,N.T.,et al, 1980
Prolactin-Secreting Pituitary Adenomas, III. Frequency & Diagnosis in Amenorrhea-Galactorrhea
JAMA 244:1329-1332, Keye,W.R.,et al, 1980
The Prolactinoma Problem
NEJM 300:313-315, Reichlin,S., 1979
Diagnostic Approaches to Pituitary Adenomas
Neurol 29:161-169, Drayer,B.,et al, 1979
Drug Therapy, Bromocriptine
NEJM 301:873-878, Parkes,D., 1979